The effect of fluvoxamine on serum prolactin and serum sodiumn concentrations: Relation to platelet 5-HT(2A) receptor status

Journal of Clinical Psychopharmacology

Volumn 17, Issue 4, 1997, Pages 292-297

  Spigset, Olav ^a   Mjörndal, Tom ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; SEROTONIN 2A RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RECEPTOR DENSITY; SODIUM BLOOD LEVEL; THROMBOCYTE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD PLATELETS; CELL MEMBRANE; FLUVOXAMINE; HUMANS; KINETICS; LYSERGIC ACID DIETHYLAMIDE; MALE; PROLACTIN; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SODIUM; WATER-ELECTROLYTE BALANCE;

EID: 0342275201     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199708000-00009     Document Type: Article

References (33)

1. Bronzo MR, Stahl SM. Galactorrhea induced by sertraline. Am J Psychiatry 1993;150:1269-70.
2. Jeffries J, Bezchlibnyk-Butler K, Remington G. Amenorrhea and galactorrhea associated with fluvoxamine in a loxapine-treated patient. J Clin Psychopharmacol 1992;12:296-7.
3. Spigset O, Hedenmalm K. Hyponatraemia and the syndrome of inappropriate secretion of antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Saf 1995;12:209-25.
4. 3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan. Neuroendocrinology 1992;55:336-43.
5. Brownfield MS, Greathouse J, Lorens SA, Armstrong J, Urban JH, van de Kar LD. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats. Neuroendocrinology 1988;47:277-83.
6. Kletzky OA, St-Michel P, Mashchak CA, Coleman BS. Lack of effect of fluvoxamine, a new serotonin reuptake inhibitor, on hypothalamic-pituitary function. Curr Ther Res 1983;33:394-400.
7. Syvälahti E, Nagy A, van Praag HM. Effects of zimeldine, a selective 5-HT uptake inhibitor, on serum prolactin levels in man. Psychopharmacology 1979;64:251-3.
8. Calil HM, Lesieur P, Gold PW, Brown GM, Zavadil AP, Potter WZ. Hormonal responses to zimeldine and desipramine in depressed patients. Psychiatry Res 1984;13:231-42.
9. Salzman C, Jimerson D, Vaslie R, Watsky E, Gerber J. Response to SSRI antidepressants correlates with reduction in plasma HVA: a pilot study. Biol Psychiatry 1993;34:569-71.
10. Urban RJ, Veldhuis JD. A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women. Am J Obstet Gynecol 1991;164: 147-52.
11. Price LH, Charney DS, Delgado PL, Anderson GM, Heninger GR. Effects of desipramine and fluvoxamine to prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action. Arch Gen Psychiatry 1989;46:625-31.
12. Lowy MT, Meltzer HY. Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist. Biol Psychiatry 1988;23:818-28.
13. 2A receptor blockade by amsergide fully attenuates prolactin response to d-fenfluramine in physically healthy subjects. Psychopharmacology 1996;126:24-30.
14. 1C receptors to release vasopressin in anaesthetized rats. Br J Pharmacol 1992,107:1020-8.
15. Pérgola PE, Sved AF, Vooge JL, Alper RH. Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin. Neuroendocrinology 1993;57:550-8.
16. Spigset O, Hedenmalm K. Hyponatremia during treatment with clomipramine, perphenazine, or clozapine: study of therapeutic drug monitoring samples. J Clin Psychopharmacol 1996;16:412-4.
17. Faull CM, Rooke P, Baylis PH. The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man. Clin Endocrinol (Oxf) 1991;35:423-30.
18. Spigset O, Carleborg L, Hedenmalm K, Dahlqvist R. Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans. Clin Pharmacol Ther 1995;58:399-403.
19. 3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes. Eur J Pharmacol 1984;97:87-93.
20. Bruns RF, Lawson-Wendling K, Pugsley TA. A rapid nitration assay for soluble receptors using polyethylenimine-treated filters. Anal Biochem 1983;132:74-81.
21. Lowry DH, Rosenbrough HJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951;193:265-75.
22. Markwell MAK, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978;87:206-10.
23. Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: part 1 - correlation within subjects. BMJ 1995;310:446.
24. Reichlin S. Neuroendocrinology. In: Wilson JD, Foster DW, eds. Textbook of endocrinology, 7th ed. Philadelphia: Saunders, 1985: 492-567.
25. Golden RN, Ruegg R, Brown TW, Haggerty J, Garbutt JC, Pedersen CA, Evans DL. Abnormal neuroendocrine responsivity to clomipramine in depression. Psychopharmacol Bull 1990;26: 317-20.
26. Cooper DS, Gelenberg AJ, Wojcik JC, Saxe VC, Ridgway C, Maloof F. The effect of amoxapine and imipramine on serum prolactin levels. Ann Intern Med 1981;141:1023-5.
27. 125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue. J Neurochem 1989;53:191-6.
28. Andres AH, Rao ML, Ostrowitski S, Entzian W. Human brain cortex and platelet serotonin-2 receptor binding properties and their regulation by endogenous serotonin. Life Sci 1993;52:313-21.
29. 2A receptor. J Neurochem 1994;63:465-9.
30. Spigset O, Hedenmalm K. Hyponatremia in relation to treatment with antidepressants: a survey of reports in the World Health Organization database for spontaneous reporting of adverse drug reactions. Pharmacotherapy 1997;17:348-52.
31. Frazer A, Ramsey TA, Swann A, Bowden C, Brunswick D, Garver D, Secunda S. Plasma and erythrocyte electrolytes in affective disorders. J Affect Disord 1983;5:103-13.
32. Widmer J, Bovier P, Karege F, Raffin Y, Hilleret H, Gaillard J-M, Tissot R. Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months. Neuropsychobiology 1992;26:173-9.
33. Widmer J, Stella N, Raffin Y, Bovier P, Gaillard J-M, Hilleret H, Tissot R. Blood magnesium, potassium, sodium, calcium and cortisol in drug-free depressed patients. Magnes Res 1993;6:33-41.